Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Tri

Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn's Perianal Fistulas - Iberonews

Takeda Announces Topline Results of Phase 3 ADMIRE-CD II Trial of Alofisel® (darvadstrocel) in Complex Crohn's Perianal Fistulas - Iberonews

iberonews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from iberonews.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Japan , Van Assche , Injektion Darvadstrocelum , Perianal Fistulising Crohn , Admire Cd Study Group Collaborators , Japan Pharmaceuticals , Devices Agency , European Network Of Centres , Takeda Pharmaceutical Company Ltd , Medical Devices , Products Approved , Regenerative Medical , Subjects With Complex Perianal Fistulising Crohn , European Network , Pharmaceutical Company , Takeda Receives Approval , Market Alofisel , Complex Perianal Fistulas , Mildly Active Luminal Crohn , Drug Evaluation ,